Pricing Log in Create free account

Cel-Sci Corporation (CVM) vs Impact Biomedical Inc. (IBO)

Cel-Sci Corporation and Impact Biomedical Inc. are both Biotechnology companies. Cel-Sci Corporation is the larger, with a market value of $30.6M against $27.0M — 1.1× the size. Cel-Sci Corporation has negative trailing earnings, so its P/E is not meaningful; Impact Biomedical Inc. trades at 0.2×. Impact Biomedical Inc. has the higher net margin (2,254.3% vs 0.00%) and the higher return on invested capital (−22.8% vs −169.6%). Across the 16 metrics below, Impact Biomedical Inc. leads on 10 and Cel-Sci Corporation on 6.

Valuation

Metric CVM IBO Biotechnology median
P/E n/m 0.24 8.50
P/S 38.82 653.87 9.71
P/B 1.98 1.63 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 35.01 881.33 9.21
Earnings yield (63.81%) 415.59% (33.15%)
Free cash flow yield (77.45%) (2.30%) (25.50%)

Profitability

Metric CVM IBO Biotechnology median
Gross margin 0.00% (1,111.43%) 65.16%
Operating margin 0.00% (14,600.00%) 0.00%
Net margin 0.00% 2,254.29% 0.00%
Free cash flow margin 0.00% (1,451.43%) 0.00%
Return on equity (252.53%) 24.01% (56.36%)
Return on assets (108.91%) 4.41% (48.04%)
Return on invested capital (169.59%) (22.81%) 0.00%

Growth

Metric CVM IBO Biotechnology median
Revenue growth (TTM) 20.75% — 6.02%
EPS growth (last fiscal year) 59.06% 83.48% 30.26%
Revenue growth, 5-year CAGR 16.18% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CVM IBO Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 1.48 0.16 4.72
Net debt to EBITDA 0.25 0.00 0.96

Dividend

Metric CVM IBO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CVM IBO Biotechnology median
Market cap 30.61m 26.99m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack